Department of Neurology, University Hospital Zurich and University of Zurich, 8091 Zürich, Switzerland.
Int J Mol Sci. 2017 Dec 9;18(12):2669. doi: 10.3390/ijms18122669.
Ischemic stroke is caused by a disruption in blood supply to a region of the brain. It induces dysfunction of brain cells and networks, resulting in sudden neurological deficits. The cause of stroke is vascular, but the consequences are neurological. Decades of research have focused on finding new strategies to reduce the neural damage after cerebral ischemia. However, despite the incredibly huge investment, all strategies targeting neuroprotection have failed to demonstrate clinical efficacy. Today, treatment for stroke consists of dealing with the cause, attempting to remove the occluding blood clot and recanalize the vessel. However, clinical evidence suggests that the beneficial effect of post-stroke recanalization may be hampered by the occurrence of microvascular reperfusion failure. In short: recanalization is not synonymous with reperfusion. Today, clinicians are confronted with several challenges in acute stroke therapy, even after successful recanalization: (1) induce reperfusion, (2) avoid hemorrhagic transformation (HT), and (3) avoid early or late vascular reocclusion. All these parameters impact the restoration of cerebral blood flow after stroke. Recent advances in understanding the molecular consequences of recanalization and reperfusion may lead to innovative therapeutic strategies for improving reperfusion after stroke. In this review, we will highlight the importance of restoring normal cerebral blood flow after stroke and outline molecular mechanisms involved in blood flow regulation.
缺血性脑卒中是由于大脑某一区域的血液供应中断而引起的。它会导致脑细胞和神经网络功能障碍,从而导致突发性神经功能缺损。脑卒中的病因是血管性的,但后果是神经性的。几十年来,研究人员一直致力于寻找新的策略来减少脑缺血后的神经损伤。然而,尽管投入了难以置信的巨大资金,所有针对神经保护的策略都未能证明临床疗效。目前,脑卒中的治疗包括处理病因,试图清除阻塞的血栓并使血管再通。然而,临床证据表明,脑卒中后再通的有益效果可能会受到微血管再灌注失败的影响。简而言之:再通并不等同于再灌注。如今,即使在成功再通后,临床医生在急性脑卒中治疗中仍面临着诸多挑战:(1)诱导再灌注,(2)避免出血性转化(HT),(3)避免早期或晚期血管再闭塞。所有这些参数都影响脑卒中后脑血流的恢复。对再通和再灌注分子后果的深入理解,可能会为改善脑卒中后的再灌注带来创新的治疗策略。在这篇综述中,我们将强调脑卒中后恢复正常脑血流的重要性,并概述与血流调节相关的分子机制。